By Ezequiel Minaya 
 

Federal prosecutors in Massachusetts said Thursday that CVS Pharmacy Inc. has agreed to pay $3.5 million to settle allegations that 50 of its stores in the state and New Hampshire filled hundreds of fake prescriptions over a three-year period for addictive pain killers and other controlled substances.

A message seeking comment from CVS was not immediately returned.

Authorities in the U.S. Attorney's office in the District of Massachusetts said the fraudulent prescriptions were filled between 2011 and 2014 for drugs with a total street value of over $1 million. Two investigations by the Drug Enforcement Administration found a total of 523 forged prescriptions involving 50 CVS stores.

Prosecutors said the prescriptions were traced to "just a few individuals," who were not identified in the statement announcing the settlement. It was not immediately clear if there were any arrests in connection with the case. Some of the drugs obtained included oxycodone, hydrocodone and methadone.

Prosecutors alleged that simple due diligence would have uncovered the fraudulent nature of the fake prescriptions. In addition to the financial settlement, CVS has entered into a three-year compliance agreement with the DEA that requires the drugstore chain to maintain and enhance programs it has developed to stop the diversion of controlled substances, authorities said.

 

Write to Ezequiel Minaya at Ezequiel.Minaya@wsj.com

 

(END) Dow Jones Newswires

June 30, 2016 14:55 ET (18:55 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CVS Health Charts.